BKBetty A Kustiana

Betty A Kustiana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Betty A Kustiana has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Galuh Widiyarti

    Research Center for Pharmaceutical Ingredients and Traditional Medicine National Research and Innovation Agency of Indonesia (BRIN) KST BJ Habibie Kawasan Puspiptek 452 Building Selatan 15314 Tangerang Indonesia

    1 shared publication
  • Teni Ernawati

    Research Center for Pharmaceutical Ingredients and Traditional Medicine National Research and Innovation Agency of Indonesia (BRIN) KST BJ Habibie Kawasan Puspiptek 452 Building Selatan 15314 Tangerang Indonesia

    1 shared publication

Latest Publications

  • Open Access

    Recent advances in synthetic approaches for bioactive cinnamic acid derivatives

    by Betty A Kustiana, Galuh Widiyarti, Teni Ernawati

    Cinnamic acid derivatives represent a significant class of biologically active compounds exhibiting a broad spectrum of activities, such as antifungal, antidengue, antimetastatic, antimicrobial, antibacterial, and anticancer properties. Their preparation has attracted considerable attention due to their versatile applications across the pharmaceutical, food, and chemical sectors. This review elucidates the functional groups of cinnamic acid that are instrumental in the rational design of biologically active derivatives. A comprehensive representative of recent advancements in synthetic methodologies over the past five years is presented, particularly emphasizing the active scaffolds of bioactive cinnamic acid derivatives. The review provides a strategic overview of alternative synthetic routes and highlights the latest innovations, including more efficient, highly selective, and environmentally sustainable approaches. Given the widespread incorporation of the cinnamic acid framework in various therapeutic agents, this review delivers critical insights into a molecular design for hit-to-lead optimization, offering detailed synthetic strategies for diverse functional modifications. By critically examining these methodologies, the paper underscores their role in expanding the utility of cinnamic acid derivatives and addressing prevailing challenges.